Actively Recruiting

Age: 18Years +
All Genders
NCT07282470

Epigenetic Profiling and Liquid Biopsy: Perspectives for Personalized Medicine in Meningioma Patients - MIND

Led by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Updated on 2026-02-10

210

Participants Needed

1

Research Sites

74 weeks

Total Duration

On this page

Sponsors

F

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Lead Sponsor

U

University of Milan

Collaborating Sponsor

AI-Summary

What this Trial Is About

Meningiomas are the most common primary intracranial tumors. Current treatment relies on surgical resection and radiotherapy, but molecular predictors for recurrence are lacking. This study aims to investigate epigenetic features, specifically histone post-translational modifications (PTMs) and DNA methylation, to stratify patients. The study involves a retrospective cohort to define an epigenetic signature and a prospective cohort to validate it in tissues and liquid biopsies (plasma/EVs).

CONDITIONS

Official Title

Epigenetic Profiling and Liquid Biopsy: Perspectives for Personalized Medicine in Meningioma Patients - MIND

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient aged 18 years or older
  • First diagnosis of uni-focal meningioma of the convexity
  • Macroscopical total resection (Simpson 1-3)
  • Surgery performed between 2007 and 2016 (retrospective cohort only)
  • Availability of FFPE sample and medical records (retrospective cohort only)
Not Eligible

You will not qualify if you...

  • Genetic syndromes
  • Diffuse Meningeal Meningiomatosis
  • Patients who underwent experimental treatment in neo-adjuvant setting
  • Previous surgical or medical treatment for another meningioma (prospective cohort only)
  • Positive oncological history such as breast cancer (prospective cohort only)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Fondazione IRCCS Istituto Neurologico Carlo Besta

Milan, Italy

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here